United States · Platforms & data · The Motley Fool

Abbott Laboratories vs. UnitedHealth: Does Health Innovation or Health Insurance Make for a Better Stock to Buy?

Published by The Motley Fool · United States 2 h ago

Abbott's $7.4B free cash flow and 0.3x debt load contrast sharply with UnitedHealth's $16.1B free cash flow but higher leverage and government policy risk.

Read the full article on The Motley Fool Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.fool.com)

Also worth reading

MarketWatch

Young Americans are giving up on car ownership. It’s a path to financial freedom for some.

Seeking Alpha

Insider trades: Blackberry, Accenture and Cleveland-Cliffs among notable names

MarketBeat

Lotus Technology Targets EBIT Profitability Before 2030 as Deliveries, Margins Improve

Investing.com

Violence flares in Paris after largely peaceful protests across France

Benzinga

Myro (MYRO) Price Prediction: 2025, 2026, 2030

Morningstar